Company Filing History:
Years Active: 2022
Title: Mark George Ford Sun: Innovator in Genetic Therapeutics
Introduction
Mark George Ford Sun is a prominent inventor based in Toronto, Canada. He has made significant contributions to the field of genetic therapeutics, particularly in the treatment of disorders associated with genetic mutations. His innovative work has the potential to impact many lives by providing new avenues for treatment.
Latest Patents
Mark George Ford Sun holds a patent for "Therapeutic splice-switching oligonucleotides." This patent provides compositions and methods for treating disorders associated with mutations in the CEP290 gene. The disclosure includes synthetic polynucleotides designed to skip a reading-frame of a CEP290 pre-RNA, resulting in a CEP290 translated product that lacks one or more exons. Additionally, the patent outlines methods for treating patients using these synthetic polynucleotides.
Career Highlights
Mark is currently associated with Deep Genomics Incorporated, a company focused on leveraging artificial intelligence to advance genetic medicine. His work at Deep Genomics highlights his commitment to integrating technology with genetic research to develop innovative therapeutic solutions.
Collaborations
Mark collaborates with talented individuals in his field, including Daniele Merico and Joao Antonio Lourenco Goncalves. These collaborations enhance the research and development efforts at Deep Genomics, fostering an environment of innovation and discovery.
Conclusion
Mark George Ford Sun is a key figure in the realm of genetic therapeutics, with a focus on innovative solutions for genetic disorders. His contributions through patents and collaborations are paving the way for advancements in medical treatments.